NEW YORK (GenomeWeb) – Two new studies resulting from the ongoing Tracking Cancer Evolution through Therapy (TRACERx) trial in the UK illustrate important features of the heterogeneity and clonal evolution of non-small cell lung cancer and begin to build evidence for the use of liquid biopsy for recurrence monitoring and predicting response to adjuvant treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.